Jasvir Pandher

Associate Director


asvir plays an integral role in LeapFrog’s Asia investment team, providing support across the full investment process and building value at LeapFrog’s portfolio companies. Jasvir was a key member of the team that made LeapFrog’s first investment into healthcare within Asia – $23 million in Ascent Meditech in India. Prior to LeapFrog, Jasvir was an investment analyst at Davita Healthcare Partners in Singapore, where he originated, executed and managed Asia-Pacific healthcare investments.

Previously, he worked as an Analyst at Citigroup in Australia, where he advised on several M&A and capital-market transactions, including Veda Group’s $1.2 billion IPO and Qantas’s takeover defence. Jasvir holds a Bachelor’s Degree of Laws and Commerce from the University of Western Australia, where he graduated with honours.

  • Building value in LeapFrog’s portfolio companies
  • Instrumental to the integration and management of Express Clinics, India’s largest chain of private, multi-specialty medical clinics
  • Bachelor of Laws and Commerce (Honours)